Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150852167> ?p ?o ?g. }
- W2150852167 endingPage "3419" @default.
- W2150852167 startingPage "3408" @default.
- W2150852167 abstract "Abstract Fibroblast growth factors (FGF) and their high-affinity receptors (FGFR) represent an extensive cellular growth and survival system. Aim of this study was to evaluate the contribution of FGF/FGFR-mediated signals to the malignant growth of non-small cell lung cancer (NSCLC) and to assess their potential as targets for therapeutic interventions. Multiple FGFR mRNA splice variants were coexpressed in NSCLC cells (n = 16) with predominance of FGFR1. Accordingly, both expression of a dominant-negative FGFR1 (dnFGFR1) IIIc-green fluorescent protein fusion protein and application of FGFR small-molecule inhibitors (SU5402 and PD166866) significantly reduced growth, survival, clonogenicity, and migratory potential of the majority of NSCLC cell lines. Moreover, dnFGFR1 expression completely blocked or at least significantly attenuated s.c. tumor formation of NSCLC cells in severe combined immunodeficient mice. Xenograft tumors expressing dnFGFR1 exhibited significantly reduced size and mitosis rate, enhanced cell death, and decreased tissue invasion. When FGFR inhibitors were combined with chemotherapy, antagonistic to synergistic in vitro anticancer activities were obtained depending on the application schedule. In contrast, simultaneous blockage of FGFR- and epidermal growth factor receptor-mediated signals exerted synergistic effects. In summary, FGFR-mediated signals in cooperation with those transmitted by epidermal growth factor receptor are involved in growth and survival of human NSCLC cells and should be considered as targets for combined therapeutic approaches. [Mol Cancer Ther 2008;7(10):3408–19]" @default.
- W2150852167 created "2016-06-24" @default.
- W2150852167 creator A5015956160 @default.
- W2150852167 creator A5026319974 @default.
- W2150852167 creator A5027030441 @default.
- W2150852167 creator A5029917133 @default.
- W2150852167 creator A5030384887 @default.
- W2150852167 creator A5031480733 @default.
- W2150852167 creator A5033125669 @default.
- W2150852167 creator A5035532329 @default.
- W2150852167 creator A5043913136 @default.
- W2150852167 creator A5049252121 @default.
- W2150852167 creator A5067062583 @default.
- W2150852167 creator A5076913706 @default.
- W2150852167 creator A5081821029 @default.
- W2150852167 creator A5088951200 @default.
- W2150852167 date "2008-10-01" @default.
- W2150852167 modified "2023-09-24" @default.
- W2150852167 title "Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition" @default.
- W2150852167 cites W1510884166 @default.
- W2150852167 cites W1598196431 @default.
- W2150852167 cites W1704220988 @default.
- W2150852167 cites W1828331863 @default.
- W2150852167 cites W1974903851 @default.
- W2150852167 cites W1976543333 @default.
- W2150852167 cites W1977332018 @default.
- W2150852167 cites W1981102741 @default.
- W2150852167 cites W1991568411 @default.
- W2150852167 cites W1992388470 @default.
- W2150852167 cites W1995811812 @default.
- W2150852167 cites W1998322093 @default.
- W2150852167 cites W2006058088 @default.
- W2150852167 cites W2013623922 @default.
- W2150852167 cites W2014038672 @default.
- W2150852167 cites W2014061811 @default.
- W2150852167 cites W2015545351 @default.
- W2150852167 cites W2018257566 @default.
- W2150852167 cites W2023781626 @default.
- W2150852167 cites W2033134892 @default.
- W2150852167 cites W2035280941 @default.
- W2150852167 cites W2048154391 @default.
- W2150852167 cites W2052457592 @default.
- W2150852167 cites W2053393533 @default.
- W2150852167 cites W2056983875 @default.
- W2150852167 cites W2062679793 @default.
- W2150852167 cites W2064246402 @default.
- W2150852167 cites W2068038502 @default.
- W2150852167 cites W2077945404 @default.
- W2150852167 cites W2078542230 @default.
- W2150852167 cites W2084192521 @default.
- W2150852167 cites W2089380369 @default.
- W2150852167 cites W2110017050 @default.
- W2150852167 cites W2118411662 @default.
- W2150852167 cites W2122696814 @default.
- W2150852167 cites W2122892477 @default.
- W2150852167 cites W2124511021 @default.
- W2150852167 cites W2124862241 @default.
- W2150852167 cites W2128303031 @default.
- W2150852167 cites W2130638068 @default.
- W2150852167 cites W2134964659 @default.
- W2150852167 cites W2138178479 @default.
- W2150852167 cites W2157467930 @default.
- W2150852167 doi "https://doi.org/10.1158/1535-7163.mct-08-0444" @default.
- W2150852167 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2879863" @default.
- W2150852167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18852144" @default.
- W2150852167 hasPublicationYear "2008" @default.
- W2150852167 type Work @default.
- W2150852167 sameAs 2150852167 @default.
- W2150852167 citedByCount "96" @default.
- W2150852167 countsByYear W21508521672012 @default.
- W2150852167 countsByYear W21508521672013 @default.
- W2150852167 countsByYear W21508521672014 @default.
- W2150852167 countsByYear W21508521672015 @default.
- W2150852167 countsByYear W21508521672016 @default.
- W2150852167 countsByYear W21508521672017 @default.
- W2150852167 countsByYear W21508521672018 @default.
- W2150852167 countsByYear W21508521672019 @default.
- W2150852167 countsByYear W21508521672020 @default.
- W2150852167 countsByYear W21508521672021 @default.
- W2150852167 countsByYear W21508521672022 @default.
- W2150852167 countsByYear W21508521672023 @default.
- W2150852167 crossrefType "journal-article" @default.
- W2150852167 hasAuthorship W2150852167A5015956160 @default.
- W2150852167 hasAuthorship W2150852167A5026319974 @default.
- W2150852167 hasAuthorship W2150852167A5027030441 @default.
- W2150852167 hasAuthorship W2150852167A5029917133 @default.
- W2150852167 hasAuthorship W2150852167A5030384887 @default.
- W2150852167 hasAuthorship W2150852167A5031480733 @default.
- W2150852167 hasAuthorship W2150852167A5033125669 @default.
- W2150852167 hasAuthorship W2150852167A5035532329 @default.
- W2150852167 hasAuthorship W2150852167A5043913136 @default.
- W2150852167 hasAuthorship W2150852167A5049252121 @default.
- W2150852167 hasAuthorship W2150852167A5067062583 @default.
- W2150852167 hasAuthorship W2150852167A5076913706 @default.
- W2150852167 hasAuthorship W2150852167A5081821029 @default.
- W2150852167 hasAuthorship W2150852167A5088951200 @default.
- W2150852167 hasBestOaLocation W21508521671 @default.
- W2150852167 hasConcept C121608353 @default.